Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.55%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.98%2016-08-23
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,8930.19%2016-07-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-08-11
Mr. James J. VaughnChief Commercial Officer29,079less than 0.1%2016-08-08
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.2-3.16327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.022702-2.37
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.35-8.6235,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.22-8.2129,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.1-3.79327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.2-0.9835,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.852.37327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.1-0.935,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92-5.7932,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.6138-4.4234,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.01-3.0115,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856-5.7931,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.33.74326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08-5.7924,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-17.926,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-16.7627,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-21.5624,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-9.8427,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-10.0612,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-10.0624,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.121.3430,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.984.0630,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.12-4.1830,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.960.5330,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.16-4.2129,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-15.66Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-13.3429,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-17.33Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-17.1529,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-11.65Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-15.9121,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-17.386,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-21.16Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-20.04Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-18.8821,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-24.24Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-25.3722,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-27.216,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-14.29Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-8.3122,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-11.54Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-12.3322,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.2-3.58312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.211.19Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.77-0.79Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.22-2.4822,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$27189-2.3312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.11-1.31312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.31.07Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.48-4.4924,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.78-3.3322,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.62-0.6Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.365.1423,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.750.5311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$2781-2.322,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-6.98311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.28-4.9722,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.58-5.3815,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.66-3.65311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$2781-2.324,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-16.28308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-12.07Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.51-6.3518,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-10.79308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-14.02Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-20.6621,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-24.466,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-23.71Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-20.9221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-15.9318,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-11.09308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-12.07Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-11.9218,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-21.79313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-23.11Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-18.9118,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-19.8221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-16.236,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-20.01318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-20.13Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-20.4221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-20.4221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-21.6319,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-25.33318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-23.78Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-21.9817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-21.9817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-20.8513,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-21.3323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-26.07Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-26.4817,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-27.05
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-27.6713,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-28.14
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-27.536,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-28.49
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-28.57
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-29.627,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-29.07327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-27.63
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-26.376,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-23.18
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-23.367,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-23.98Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-26.7617,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-26.712,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-12.07Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.48-5.0712,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-7.6712,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.58-5.04
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-6.227,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-7.37
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-7.112,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.53-6.29
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.08-5.8914,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-8.316,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-5.7917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-5.3814,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-4.9333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.95-5.07Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-5.7917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.68-5.246,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.12-1.68288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.26-1.936,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.7-2.08338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.52-3.44288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.2-3.16Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-5.14288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-5.7917,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-7.8314,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-20.25Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-25.16343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-21.9317,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-21.9111,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-24.214,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-21.86348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-16.76Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-24.6514,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-25.062,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-24.61353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-24.02Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-13.4814,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-26.526,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-22.96358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-24.11Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-25.46Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-26.6214,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-20.66363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-20.92Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-20.92Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-21.35Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-22.3413,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-21.95367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-18.23
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-20.1326,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-22.14
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-22.93Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-21.717,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-11.95
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-12.71Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-8.6213,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-7.28
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-6.496,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.65-5.55372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.95-5.07Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.98-5.7218,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-7.73Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-12.8813,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-12.3377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-12.27Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-12.27Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-12.3377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-15.1219,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-15.04Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-11.8913,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-12.39
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-12.39
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-12.39
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-11.51
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-11.51
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-11.51
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-9.22
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-9.22
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-9.22
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-7.44Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.38-5.99
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-5.99
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-5.99
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-6.25382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-10.09
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-10.18
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-10.18
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-8.2820,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-8.2820,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.240.08
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.090.08
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.130.08
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.60.76Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.60.76Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.18-0.3414,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.02-4.116,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.1-0.15Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.1-0.9Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.7-1.35382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-5.7917,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.85-4.217,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.2-3.93Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.151.34387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.8-3.33Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-7.737,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.63-6.19
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.72-4.63
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.16-6.19
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.311.81
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.161.7
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.781.81
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.351.19392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.98-4.8
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.66-4.8
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.53-3.55
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.19-3.12
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.48-3.12
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.8-3.16Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.52-1.53
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.5-0.837,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.741.7
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.491.7
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.947.76
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1619.476,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.821.23392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.615.55Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5518.247,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.226.77Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.219.477,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.114.6392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.87.94Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.154.437,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.154.437,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.9-0.266,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.05-4.45392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.2-3.581,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-4.97,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.6-2.73392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.911.8118,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.82.691,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.120.73
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.920.73
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.680.69
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.450.767,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.61-3.51
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.06-3.55
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.3-3.55
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.753.25392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.48-0.3819,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.2-1.05Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.831.747,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.081.31Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.93.94Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.923.49Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.324.19Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.21.62Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.55-1.97Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.257.89Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7910.89Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.328.6Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.328.6Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.42.97Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.381.34Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.785.27Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.125.27Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.084.56Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.443.65Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.062.69Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.72.69Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9212.78Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2112.78Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3513.36Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5117.19Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0817.19Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244418.83Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.224.73Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.224.73Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8725.26Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.621.4Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6519.2Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6816.16Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.217.45Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.616.52Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514050.74Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.146.23Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.444.39Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527989.1Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7874.7Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.477.4Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5375.75Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1578.12Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9278.12Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6482.43Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1382.43Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0783.58Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7383.58Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8181.68Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.381.68Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9475.98Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6175.98Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5675.05Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4277.64Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7677.64Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.575.87Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.279.33Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5880.56Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2380.56Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2878.85Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2105.93Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41102.15Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528386.43Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.0487.76Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2467.17Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6866.23Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.268.99Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.870.08Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.456.37Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.556.09Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1456.28Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538935.63Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338636.68Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4836.05Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3235.63Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7933.03Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1554.72Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7954.72Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.653.11Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7850.66Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5255.09Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9455.09Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3453.91Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2552.93Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8751Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.631.11Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9529.38Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8429.19Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8830.34Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7830.21Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.237.32Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3331.64Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8831.97Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5831.9Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2527.75Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.129.19Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9227.69Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179824.61Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6524.85Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6527.26Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0427.62Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1431.11Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8527.01Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7432.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2732.03Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6832.03Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9132.03Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6535.07Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010031.9Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4435.35Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8835.28Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.835.35Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8835.35Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0435.84Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1735.42Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1164.77
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1164.77
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6244.39
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8949.12
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199538.84
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9146.8
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6246.8
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8146.8
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4546.8
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.631.11
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5235.56
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7234.94
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.134.94
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4634.94
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8234.94
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2833.77
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.643.57
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.974.39
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.835.98
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5537.9
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.622.58
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3628.06
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3628.06
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.226.52
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8535.91
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0230.79
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1137.04
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1137.04
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.843.37
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9832.76
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9832.76
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.631.57
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.730.79
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3229.57
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.417.19
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3516.37
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4821.06
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6515.05
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0316.26
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0811.45
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.246068.83
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1211.03
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125225.62
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1536.97
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20231.9
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0432.43
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7732.5
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4632.5
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0532.5
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2846.64
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522540.69
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.236.9
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6453.19
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0840.02
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.828.81
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1530.4
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2216.83
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1214.65
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1915
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.483.29
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8916.42
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9314.2
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4119.91
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8414.35
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4413.66
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9230.85
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8432.96
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2833.98
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.433.91
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5934.8
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3740.62
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9232.5
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9935.7
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1624.55
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018838.77
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9237.68
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2950.23
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8961.64
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8761.64
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.161.64
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0961.64
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7759.01
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6659.01
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.959.01
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6259.01
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9570.19
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6170.19
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0270.19
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.670.19
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8470.19
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9570.19
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4458.72
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.561.74
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2452.75
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4353.73
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1544.31
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8744.31
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.344.31
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2844.31
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2644.31
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.243.76
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1545.83
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8845.83
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.445.75
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0945.83
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4145.83
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1645.1
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2634.39
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1442.29
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.242.29
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7342.29
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0442.29
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0442.29
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5744.55
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5644.55
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0444.55
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6744.55
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5544.55
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4445.58
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8139.06
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8522.24
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4522.24
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1722.24
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0722.24
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.720.07
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3828.06
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8828.06
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1328.06
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2628.06
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.7287.76Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.2187.76Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.1787.76Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79119.83Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21119.83Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK